BOCA RATON, FL--(Marketwire - October 20, 2010) - David H. Fater, CEO of Vicor Technologies, Inc. (OTCBB: VCRT), today announced that on October 12, 2010 the U.S. Patent Office issued United States Patent #7,811,992 to Vicor for the use of a molecule discovered using the Company's novel drug discovery platform. The molecule covered by the patent has been shown to diminish the size and severity of infarctions associated with acute myocardial infarctions (heart attacks) and strokes.